CenterWatch

Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

UPDATED

Birmingham Alabama

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Arizona

Banner Sun Health Research Institute
Sun City Arizona 85351

A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 3-arm, Phase 4 Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Apathy, Motor Symptoms, and Mood

Banner Sun Health Research Institute
Sun City Arizona 85351

The Parkinson's Progression Markers Initiative (PPMI)

View More ▼

UPDATED

Phoenix Arizona

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Phoenix Arizona

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

UPDATED

Scottsdale Arizona

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Scottsdale Arizona

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

UPDATED

Sun City Arizona

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Sun City Arizona

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Gilbert Arizona

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Gilbert Arizona 85234

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Gilbert Arizona 85234

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Gilbert Arizona

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Sun City Arizona 85351

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Sun City Arizona 85351

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Tucson Arizona

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Tucson Arizona

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Tucson Arizona 85724

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

California

Neurosearch-Inc
Torrance California 90505

A Clinical Trial for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients using ADS-5102 (amantadine HCL) Extended Release Capsules

View More ▼

UPDATED

Fountain Valley California

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Fountain Valley California

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

UPDATED

Pasadena California

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Pasadena California

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

UPDATED

Reseda California

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Reseda California

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

UPDATED

Sacramento California

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Sacramento California

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

UPDATED

Torrance California

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Torrance California

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

UPDATED

Ventura California

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

UPDATED

Ventura California

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Fountain Valley California 92708

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Fresno California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Fresno California 93710

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Fresno California 93710

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Fresno California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Irvine California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Irvine California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Irvine California 92697

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

La Jolla California 92037

A clinical study for patients with Parkinson's Disease

Long Beach California 90806

A clinical trial seeking patients for a research study for the treatment of Parkinson's Disease

Long Beach California 90806

A Phase 1 clinical study for patients with Parkinson's Disease

Los Angeles California 91403

A clinical study for patients with Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease or Huntington's Disease

Los Angeles California

A clinical trial seeking patients for a research study for the treatment of Parkinson's Disease

Los Angeles California

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease